Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. slides, 8-K earnings release, 10-Q stay in one workspace.
RNA
$7.50
-5.78%
RNA
· Atrium Therapeutics, Inc.
$7.50
-0.46 (-5.78%)
At close · Nov 12
Return incl. dividend (before tax)
Market Cap
$128.29M
Shares
21.57M
Volume · Nov 12
294.72K
Avg daily vol (3M)
288.66K
All webcasts
Earnings call · FY2026 Q2
Atrium Therapeutics, Inc. (RNA) Q2 2026 Earnings Call
Revenue
$3.00M
-21.9% YoY
Diluted EPS
-$1.18
Net income
-$20.19M
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Company presentation
Slides
8 pages · use arrow keys or swipe to navigate
SEC filing · Item 2.02
8-K earnings release
Filed Aug 13, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 13, 2026 · complete as-filed document